Skip to main content
Premium Trial:

Request an Annual Quote

Celera Signs on Toronto s Hospital for Sick Children As Database Subscriber

NEW YORK, Nov. 21 - Celera announced Tuesday that the Hospital for Sick Children in Toronto, one of Canada’s major medical research centers, had signed up for a multi-year subscription to some of its database products.

The financial terms were not disclosed, but academic subscribers to Celera’s database pay between $6,000 and $15,000 per scientist, the company has said previously.

The Hospital for Sick Children, which will access Celera’s database through its Web-based Celera Discovery system, is Celera’s first academic subscriber in Canada.

" Access to Celera's database products should facilitate scientific discovery by allowing researchers at The Hospital for Sick Children to concentrate on identifying disease-causing genes, which opens the door for improved diagnosis and potentially new treatments for disease," Lap-Chee Tsui, HSC's geneticist-in-chief, said in a statement. “We look forward to collaborating further with Celera in the future. “

The other publicly disclosed academic subscribers to Celera’s database include The Weizmann Institute of Science in Israel; the California Institute of Technology; The Institute for Genomic Research; Howard Hughes Medical Institute; The University of Texas Southwestern Medical Center at Dallas; The University of Cincinnati; Ohio State University; The Australian National Health and Medical Research Council; and Vanderbilt University.

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.